DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/t2g38j/malignant_glioma) has announced the addition of the "Malignant Glioma - Pipeline Review, H2 2013" report to their offering.
'Malignant Glioma - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Malignant Glioma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Malignant Glioma.
Scope
- A snapshot of the global therapeutic scenario for Malignant Glioma.
- A review of the Malignant Glioma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Malignant Glioma pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Key Topics Covered:
Introduction
Malignant Glioma Overview
Therapeutics Development
Late Stage Products
Clinical Stage Products
Early Stage Products
Drug Profiles
Eir-060 - Drug Profile
Dendritic Cell Vaccine - Drug Profile
Dendritic Cell Vaccine - Drug Profile
Carboxyamidotriazole Orotate - Drug Profile
SL-701 - Drug Profile
Dendritic Cell Vaccine - Drug Profile
Dendritic Cell Vaccine - Drug Profile
SAR-245409 - Drug Profile
WT1 Peptide Vaccine - Drug Profile
celecoxib + Dendritic Cell Vaccine + [temozolomide] + Radiation Therapy - Drug Profile
Dendritic Cell Vaccine - Drug Profile
Peptide Vaccine + [sargramostim] - Drug Profile
ALD-451 - Drug Profile
First Generation Attenuated Strain Of Reovirus - Drug Profile
Featured News & Press Releases
Appendix
List of Tables
List of Figures
Companies Mentioned
Sanofi
Cytomedix, Inc.
Stemline Therapeutics, Inc.
EirGen Pharma Ltd.
Tactical Therapeutics, Inc
For more information visit http://www.researchandmarkets.com/research/t2g38j/malignant_glioma
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
